Kapszulás endoszkópia szerepe portalis hypertensióban tisztázatlan eredetu gastrointestinalis vérzés esetén

Translated title of the contribution: Evaluation of capsule endoscopy results in patients with portal hypertension and obscure gastrointestinal bleeding

Márta Kovács, Péter Pák, Artúr Németh, Gábor Pák, J. Fehér, I. Rácz

Research output: Contribution to journalArticle

Abstract

Background and aims: wLimited number of data are available on small bowel changes due to portal hypertension. The present retrospective, comparative study was aimed to analyse the diagnostic yield and to describe the findings with capsule endoscopy of cirrhotic patients with obscure gastrointestinal bleeding. Patients and methods: Capsule endoscopy findings of 11 cirrhotic patients with portal hypertension and 22 non-cirrhotic patients with gastrointestinal bleeding who had undergone non-diagnostic upper endoscopy and colonoscopy were compared. Capsule video recordings were evaluated by two investigators at both workplaces. Patients after capsule endoscopy were followed-up until a mean of 19 (1-42) months. Results: In total 7 men and 5 women were examined at two medical centres in 48 months with a mean age of 66.2 (± 7.6) years. The average period between the first clinical symptoms and capsule endoscopy was 15.7 (± 14.9) months. During this period patients were hospitalized in an average of 2.8 (± 1.3) times and 7.9 examinations were performed per patients prior to capsule endoscopy. A small bowel bleeding source was diagnosed in all 11 patients. Two definitive bleeding sources were observed in 7 patients (63%). Lesions connected to portal hypertension were found in all patients (8 angiodysplasias, 2 portal hypertensive enteropathies and 1 bowel varix). During the follow-up period rebleeding occurred in 27.3% of cirrhotic patients compared with 18.2% rebleeding rate in the control group. Conclusion: Capsule endoscopy is a useful method in patients with portal hypertensionith obscure gastrointestinal bleeding after negative upper endoscopy and colonoscopy. Multiple angiodysplasias are often diagnosed in the background of small bowel bleedings, and several bleeding sources frequently occur in these patients.

Original languageHungarian
Pages (from-to)1491-1497
Number of pages7
JournalOrvosi Hetilap
Volume148
Issue number32
DOIs
Publication statusPublished - Aug 12 2007

Fingerprint

Capsule Endoscopy
Portal Hypertension
Hemorrhage
Angiodysplasia
Colonoscopy
Endoscopy
Video Recording
Varicose Veins
Workplace
Capsules

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kapszulás endoszkópia szerepe portalis hypertensióban tisztázatlan eredetu gastrointestinalis vérzés esetén. / Kovács, Márta; Pák, Péter; Németh, Artúr; Pák, Gábor; Fehér, J.; Rácz, I.

In: Orvosi Hetilap, Vol. 148, No. 32, 12.08.2007, p. 1491-1497.

Research output: Contribution to journalArticle

Kovács, Márta ; Pák, Péter ; Németh, Artúr ; Pák, Gábor ; Fehér, J. ; Rácz, I. / Kapszulás endoszkópia szerepe portalis hypertensióban tisztázatlan eredetu gastrointestinalis vérzés esetén. In: Orvosi Hetilap. 2007 ; Vol. 148, No. 32. pp. 1491-1497.
@article{fe04bbbb9114443295fe4d270cd2b70a,
title = "Kapszul{\'a}s endoszk{\'o}pia szerepe portalis hypertensi{\'o}ban tiszt{\'a}zatlan eredetu gastrointestinalis v{\'e}rz{\'e}s eset{\'e}n",
abstract = "Background and aims: wLimited number of data are available on small bowel changes due to portal hypertension. The present retrospective, comparative study was aimed to analyse the diagnostic yield and to describe the findings with capsule endoscopy of cirrhotic patients with obscure gastrointestinal bleeding. Patients and methods: Capsule endoscopy findings of 11 cirrhotic patients with portal hypertension and 22 non-cirrhotic patients with gastrointestinal bleeding who had undergone non-diagnostic upper endoscopy and colonoscopy were compared. Capsule video recordings were evaluated by two investigators at both workplaces. Patients after capsule endoscopy were followed-up until a mean of 19 (1-42) months. Results: In total 7 men and 5 women were examined at two medical centres in 48 months with a mean age of 66.2 (± 7.6) years. The average period between the first clinical symptoms and capsule endoscopy was 15.7 (± 14.9) months. During this period patients were hospitalized in an average of 2.8 (± 1.3) times and 7.9 examinations were performed per patients prior to capsule endoscopy. A small bowel bleeding source was diagnosed in all 11 patients. Two definitive bleeding sources were observed in 7 patients (63{\%}). Lesions connected to portal hypertension were found in all patients (8 angiodysplasias, 2 portal hypertensive enteropathies and 1 bowel varix). During the follow-up period rebleeding occurred in 27.3{\%} of cirrhotic patients compared with 18.2{\%} rebleeding rate in the control group. Conclusion: Capsule endoscopy is a useful method in patients with portal hypertensionith obscure gastrointestinal bleeding after negative upper endoscopy and colonoscopy. Multiple angiodysplasias are often diagnosed in the background of small bowel bleedings, and several bleeding sources frequently occur in these patients.",
keywords = "Capsule endoscopy, Obscure gastrointestinal bleeding, Portal hypertension, Portal hypertensive enteropathy",
author = "M{\'a}rta Kov{\'a}cs and P{\'e}ter P{\'a}k and Art{\'u}r N{\'e}meth and G{\'a}bor P{\'a}k and J. Feh{\'e}r and I. R{\'a}cz",
year = "2007",
month = "8",
day = "12",
doi = "10.1556/OH.2007.28170",
language = "Hungarian",
volume = "148",
pages = "1491--1497",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "32",

}

TY - JOUR

T1 - Kapszulás endoszkópia szerepe portalis hypertensióban tisztázatlan eredetu gastrointestinalis vérzés esetén

AU - Kovács, Márta

AU - Pák, Péter

AU - Németh, Artúr

AU - Pák, Gábor

AU - Fehér, J.

AU - Rácz, I.

PY - 2007/8/12

Y1 - 2007/8/12

N2 - Background and aims: wLimited number of data are available on small bowel changes due to portal hypertension. The present retrospective, comparative study was aimed to analyse the diagnostic yield and to describe the findings with capsule endoscopy of cirrhotic patients with obscure gastrointestinal bleeding. Patients and methods: Capsule endoscopy findings of 11 cirrhotic patients with portal hypertension and 22 non-cirrhotic patients with gastrointestinal bleeding who had undergone non-diagnostic upper endoscopy and colonoscopy were compared. Capsule video recordings were evaluated by two investigators at both workplaces. Patients after capsule endoscopy were followed-up until a mean of 19 (1-42) months. Results: In total 7 men and 5 women were examined at two medical centres in 48 months with a mean age of 66.2 (± 7.6) years. The average period between the first clinical symptoms and capsule endoscopy was 15.7 (± 14.9) months. During this period patients were hospitalized in an average of 2.8 (± 1.3) times and 7.9 examinations were performed per patients prior to capsule endoscopy. A small bowel bleeding source was diagnosed in all 11 patients. Two definitive bleeding sources were observed in 7 patients (63%). Lesions connected to portal hypertension were found in all patients (8 angiodysplasias, 2 portal hypertensive enteropathies and 1 bowel varix). During the follow-up period rebleeding occurred in 27.3% of cirrhotic patients compared with 18.2% rebleeding rate in the control group. Conclusion: Capsule endoscopy is a useful method in patients with portal hypertensionith obscure gastrointestinal bleeding after negative upper endoscopy and colonoscopy. Multiple angiodysplasias are often diagnosed in the background of small bowel bleedings, and several bleeding sources frequently occur in these patients.

AB - Background and aims: wLimited number of data are available on small bowel changes due to portal hypertension. The present retrospective, comparative study was aimed to analyse the diagnostic yield and to describe the findings with capsule endoscopy of cirrhotic patients with obscure gastrointestinal bleeding. Patients and methods: Capsule endoscopy findings of 11 cirrhotic patients with portal hypertension and 22 non-cirrhotic patients with gastrointestinal bleeding who had undergone non-diagnostic upper endoscopy and colonoscopy were compared. Capsule video recordings were evaluated by two investigators at both workplaces. Patients after capsule endoscopy were followed-up until a mean of 19 (1-42) months. Results: In total 7 men and 5 women were examined at two medical centres in 48 months with a mean age of 66.2 (± 7.6) years. The average period between the first clinical symptoms and capsule endoscopy was 15.7 (± 14.9) months. During this period patients were hospitalized in an average of 2.8 (± 1.3) times and 7.9 examinations were performed per patients prior to capsule endoscopy. A small bowel bleeding source was diagnosed in all 11 patients. Two definitive bleeding sources were observed in 7 patients (63%). Lesions connected to portal hypertension were found in all patients (8 angiodysplasias, 2 portal hypertensive enteropathies and 1 bowel varix). During the follow-up period rebleeding occurred in 27.3% of cirrhotic patients compared with 18.2% rebleeding rate in the control group. Conclusion: Capsule endoscopy is a useful method in patients with portal hypertensionith obscure gastrointestinal bleeding after negative upper endoscopy and colonoscopy. Multiple angiodysplasias are often diagnosed in the background of small bowel bleedings, and several bleeding sources frequently occur in these patients.

KW - Capsule endoscopy

KW - Obscure gastrointestinal bleeding

KW - Portal hypertension

KW - Portal hypertensive enteropathy

UR - http://www.scopus.com/inward/record.url?scp=34848868479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848868479&partnerID=8YFLogxK

U2 - 10.1556/OH.2007.28170

DO - 10.1556/OH.2007.28170

M3 - Article

VL - 148

SP - 1491

EP - 1497

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 32

ER -